NRP1 and cancer: Epithelial growth factor receptor (EGFR), a transmembrane receptor, which is expressed abundantly in a number of tumor cells, and highly related to angiogenesis invasion and metastasis, has been studied intensively as a potential target for cancer therapeutics14.